By Lou Sokolovskiy When George Coulam, the owner of the Texas Renaissance Festival—America’s largest event of its kind, drawing over 500,000 visitors annually—decided it was time to retire, he...
By Lou Sokolovskiy While global healthcare megadeals still dominate the headlines, a potentially more transformative shift is happening in the U.S. lower- and middle-market space. This segment is drawing...
How artificial intelligence is upending the M&A process—and what founders must do to keep up By Lou Sokolovskiy Artificial intelligence is no longer just a buzzword in Silicon Valley....
By Lou Sokolovskiy A major study finds that over the past ten years valuations of Software-as-a-Service (SaaS) companies have traced a dramatic arc—from exuberant highs to sobering corrections—mirroring the...
By Lou Sokolovskiy A growing number of U.S. companies are betting that smaller is smarter. On July 18, health-tech firm FOXO Technologies announced plans to spin off its subsidiary,...
By Lou Sokolovskiy Net Asset Value (NAV) based lending—once a niche solution for seasoned private equity funds—is gaining traction as both a strategic liquidity tool for institutional investors and...
By Lou Sokolovskiy In the evolving corridors of American finance, a transformation is quietly remapping the terrain of mergers and acquisitions (M&A). At the center of this shift lies...
By Lou Sokolovskiy In March 2024, the payments giant Stripe quietly acquired a startup you’ve probably never heard of. Supaglue, a four-person company specializing in data integration, didn’t have...
By Lou Sokolovskiy Independent sponsors, once viewed as opportunistic outsiders in the private equity ecosystem, are increasingly operating with institutional discipline—and institutional backing. As more capital flows into deal-by-deal...
By Lou Sokolovskiy Over the past several years, private equity firms have transformed the business of American healthcare and services. In specialties ranging from dermatology and dental to HVAC...
